Related Experiment Video
Updated: Aug 16, 2025

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
Manuel G Feria1, Cecilia Chang2, Eduardo Ticona3,4
1Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Latent tuberculosis infection (LTBI) is linked to higher cardiovascular risk. LTBI patients show altered monocytes with increased inflammation, potentially contributing to coronary artery disease (CAD).
Area of Science:
- Immunology
- Cardiovascular Medicine
- Infectious Diseases
Background:
- Latent tuberculosis infection (LTBI) is increasingly recognized as a risk factor for cardiovascular disease.
- Monocyte activation and inflammatory profiles may link LTBI to coronary artery disease (CAD).
Purpose of the Study:
- To investigate monocyte activation and pro-inflammatory profiles in individuals with LTBI.
- To determine the association between these monocyte alterations and CAD in the LTBI population.
Main Methods:
- QuantiFERON-TB testing identified LTBI in adults (40-70 years) in Lima, Peru.
- Coronary computed tomography angiography assessed CAD, and flow cytometry profiled monocyte subsets.
- Monocytes were stimulated with lipopolysaccharide to measure interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) responses.
Main Results:
- Individuals with LTBI showed higher expression of CX3CR1 and CD36 on monocyte subsets.
- LTBI patients had a greater proportion of nonclassical monocytes expressing IL-6 and TNF-α.
- Lower CX3CR1 and CD36 expression on monocytes correlated with CAD in LTBI individuals.
Conclusions:
- LTBI is associated with distinct monocyte alterations, suggesting heightened inflammation and altered tissue migration.
- These monocyte changes may play a role in the pathogenesis of cardiovascular disease in LTBI patients.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

